Metabolic flux analyses of Pseudomonas aeruginosa cystic fibrosis isolates. 2016

Michael J Opperman, and Yair Shachar-Hill
Department of Plant Biology, Michigan State University, 612 Wilson Road, East Lansing, MI 48824, USA; Cell and Molecular Biology Graduate Program, Michigan State University, 2240A Biomedical and Physical Sciences Building, East Lansing 48824, USA.

Pseudomonas aeruginosa is a metabolically versatile wide-ranging opportunistic pathogen. In humans P. aeruginosa causes infections of the skin, urinary tract, blood, and the lungs of Cystic Fibrosis patients. In addition, P. aeruginosa's broad environmental distribution, relatedness to biotechnologically useful species, and ability to form biofilms have made it the focus of considerable interest. We used 13C metabolic flux analysis (MFA) and flux balance analysis to understand energy and redox production and consumption and to explore the metabolic phenotypes of one reference strain and five strains isolated from the lungs of cystic fibrosis patients. Our results highlight the importance of the oxidative pentose phosphate and Entner-Doudoroff pathways in P. aeruginosa growth. Among clinical strains we report two divergent metabolic strategies and identify changes between genetically related strains that have emerged during a chronic infection of the same patient. MFA revealed that the magnitude of fluxes through the glyoxylate cycle correlates with growth rates.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D053858 Metabolic Networks and Pathways Complex sets of enzymatic reactions connected to each other via their product and substrate metabolites. Metabolic Networks,Metabolic Pathways,Metabolic Network,Metabolic Pathway,Network, Metabolic,Networks, Metabolic,Pathway, Metabolic,Pathways, Metabolic
D064688 Metabolic Flux Analysis Measurement of cells' substrate utilization and biosynthetic output for modeling of METABOLIC NETWORKS. Analyses, Metabolic Flux,Analysis, Metabolic Flux,Flux Analyses, Metabolic,Flux Analysis, Metabolic,Metabolic Flux Analyses
D066241 Carbon-13 Magnetic Resonance Spectroscopy Magnetic resonance spectroscopy involving detection of changes in the resonance of carbon-13 nuclei in organic molecules. 13C NMR,Carbon 13 Magnetic Resonance Spectroscopy

Related Publications

Michael J Opperman, and Yair Shachar-Hill
May 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Michael J Opperman, and Yair Shachar-Hill
May 2009, Antimicrobial agents and chemotherapy,
Michael J Opperman, and Yair Shachar-Hill
September 2021, The Journal of antimicrobial chemotherapy,
Michael J Opperman, and Yair Shachar-Hill
August 2001, Lancet (London, England),
Michael J Opperman, and Yair Shachar-Hill
November 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
Michael J Opperman, and Yair Shachar-Hill
July 1991, Pathology,
Michael J Opperman, and Yair Shachar-Hill
January 2019, Frontiers in microbiology,
Michael J Opperman, and Yair Shachar-Hill
September 1983, Clinical pediatrics,
Michael J Opperman, and Yair Shachar-Hill
May 1983, Infection and immunity,
Michael J Opperman, and Yair Shachar-Hill
August 1981, Infection and immunity,
Copied contents to your clipboard!